Article info
PDFInflammatory bowel disease
Original article
Cost-effectiveness of laparoscopic ileocaecal resection versus infliximab treatment of terminal ileitis in Crohn’s disease: the LIR!C Trial
- Correspondence to Dr Willem A Bemelman, Department of Surgery, Amsterdam UMC, University of Amsterdam, Amsterdam 1012 WX, The Netherlands; w.a.bemelman{at}amc.uva.nl
Citation
Cost-effectiveness of laparoscopic ileocaecal resection versus infliximab treatment of terminal ileitis in Crohn’s disease: the LIR!C Trial
Publication history
- Received September 6, 2018
- Revised December 27, 2018
- Accepted January 4, 2019
- First published February 1, 2019.
Online issue publication
November 14, 2019
Article Versions
- Previous version (6 September 2019).
- Previous version (6 September 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.